CRSP - CRISPR Therapeutics AG
IEX Last Trade
47.72
0.170 0.356%
Share volume: 774,748
Last Updated: Fri 30 Aug 2024 09:59:57 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$47.55
0.17
0.36%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-08 | 2022-11-01 | 2023-02-21 | 2023-05-08 | 2023-08-07 | 2023-11-06 | 2024-02-21 | 2024-05-08 | |
| Total revenue | 158.000 K | 94.000 K | 6.000 K | 100.000 M | 70.000 M | 0.000 | 201.206 M | 504.000 K | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 158.000 K | 94.000 K | 6.000 K | 100.000 M | 70.000 M | 0.000 | 201.206 M | 504.000 K | |
| -40.51% | -93.62% | 1,666,566.67% | -30.00% | -100.00% | inf% | -99.75% | |||
| Operating expenses | 149.496 M | 143.623 M | 124.724 M | 122.295 M | 120.587 M | 108.989 M | 111.623 M | 94.125 M | |
| Selling general and admin | 26.273 M | 27.001 M | 21.169 M | 22.360 M | 19.032 M | 18.291 M | 16.479 M | 17.953 M | |
| Research and development | 123.223 M | 116.622 M | 103.555 M | 99.935 M | 101.555 M | 90.698 M | 95.144 M | 76.172 M | |
| Total expenses | 183.418 M | 182.482 M | 131.547 M | 164.487 M | 165.223 M | 132.411 M | 131.623 M | 141.091 M | |
| -0.51% | -27.91% | 25.04% | 0.45% | -19.86% | -0.60% | 7.19% | |||
| Operating income | -183.260 M | -182.388 M | -131.541 M | -64.487 M | -95.223 M | -132.411 M | 69.583 M | -140.587 M | |
| Ebit | -183.260 M | -182.388 M | -131.541 M | -64.487 M | -95.223 M | -132.411 M | 69.583 M | -140.587 M | |
| Pretax income | -179.716 M | -175.124 M | -120.051 M | -51.745 M | -76.817 M | -111.740 M | 89.580 M | -115.867 M | |
| -2.56% | -31.45% | -56.90% | 48.45% | 45.46% | -180.17% | -229.34% | |||
| Income tax | 6.118 M | -575.000 K | -9.476 M | 1.320 M | 923.000 K | 412.000 K | 233.000 K | 724.000 K | |
| Net income basic | -185.834 M | -174.549 M | -110.575 M | -53.065 M | -77.740 M | -112.152 M | 89.347 M | -116.591 M | |
| 6.07% | 36.65% | 52.01% | -46.50% | -44.27% | 179.67% | -230.49% | |||
| Net income | -185.834 M | -174.549 M | -110.575 M | -53.065 M | -77.740 M | -112.152 M | 89.347 M | -116.591 M | |
| 6.07% | 36.65% | 52.01% | -46.50% | -44.27% | 179.67% | -230.49% |